Breaking News

TOT Biopharm Opens Suzhou Production Facility

December 3, 2012

Completes first stage of construction

TOT Biopharm Co. Ltd. has completed the first stage of construction of its $100 million factory complex in eastern China's Suzhou Industrial Park. The 50,000-sq.-m. facility complex specializes in the R&D, production and marketing of anti-cancer drugs globally. The company's core products include liposomal technology-based specialty drugs, biologics and innovative drugs.
 
The first stage of the new factory complex includes an oral anti-cancer drug plant with separate production facilities for cytotoxics and non-cytotoxics, an injected anti-cancer drug plant, and a GMP pilot plant with 500L cell culture/ purification/filling capacity. The company will begin the second-stage of construction to expand its production scale.

blog comments powered by Disqus
  • CMOs: A Flexibility Alternative

    CMOs: A Flexibility Alternative

    Philip K. Burns, CRO-Consulting||January 28, 2016
    A look at how to include CMOs as an option to improve overall flexibility

  • A Look at DCAT Week ‘16

    Tim Wright, Editor||January 28, 2016
    On the pulse of the pharmaceutical manufacturing value chain, DCAT Week ‘16 will deliver top-flight education programs and networking events.

  • CMC Biologics: Growing Through Innovation

    Tim Wright, Editor||January 28, 2016
    The new chief exec talks about industry trends and growth plans.